Principal investigator
Olga Piskareva
Senior Lecturer · Principal Investigator
Biomaterials · Drug development · Drug resistance · Genomics
About
Research profile
Olga Piskareva combines tumour organoids, molecular biology and tissue-engineered model systems to study neuroblastoma, metastasis and therapeutic response.
Expertise
Research interests
01Biomaterials
02Drug development
03Drug resistance
04Genomics
05Immunology
06Metastasis
07Neuroblastoma
08Proteomics
09Systems biology
10Therapeutics
11Tissue engineering
Lab members
Olga’s research team
No lab members are currently listed.
Selected outputs
Highlighted publications
The triad in current neuroblastoma challenges: Targeting antigens, enhancing effective cytotoxicity and accurate 3D in vitro modelling
In vivo cisplatin-resistant neuroblastoma metastatic model reveals TNFRSF4 as an independent prognostic factor of survival in neuroblastoma
Three-dimensional In Vitro Biomimetic Model of Neuroblastoma using Collagen-based Scaffolds.
A Context-Dependent Role for MiR-124-3p on Cell Phenotype, Viability and Chemosensitivity in Neuroblastoma in vitro.
Industry & translation
Turning research into impact.
TERG works with academic, clinical and industry partners to move biomaterials, devices and regenerative technologies towards patient benefit.
Industry, spin-outs and collaborationContact
Start a conversation.
For research, collaboration and supervision enquiries, email olgapiskareva@rcsi.com.
Lab contact details